Spelling suggestions: "subject:"transforming growth factors."" "subject:"ransforming growth factors.""
1 |
Lovastatin decreases TGF-ß1 concentration of glomerular endothelial cells cultured in high glucoseLanxon-Cookson, Erinn Claire, January 2008 (has links) (PDF)
Thesis (M.S. in exercise science)--Washington State University, May 2008. / Includes bibliographical references (p. 48-59).
|
2 |
Modeling and analysis of the transforming growth factor beta signaling pathwayChung, Seung-Wook. January 2008 (has links)
Thesis (M.C.E.)--University of Delaware, 2008. / Principal faculty advisor: Babatunde Ogunnaike, Dept. of Chemical Engineering. Includes bibliographical references.
|
3 |
Role of activin receptor-like kinase 7 (ALK7) in human trophoblast cells /Munir, Sadia. January 2008 (has links)
Thesis (Ph.D.)--York University, 2008. Graduate Programme in Biology. / Typescript. Includes bibliographical references. Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&res_dat=xri:pqdiss&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft_dat=xri:pqdiss:NR46006
|
4 |
Activin and a putative novel activin receptor-like kinase in the human placentaNi, Xueying. January 1999 (has links)
Thesis (M. Sc.)--York University, 1999. Graduate Programme in Biological Science. / Typescript. Includes bibliographical references (leaves 71-85). Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://wwwlib.umi.com/cr/yorku/fullcit?pMQ39215.
|
5 |
Homo & heterodimeric TGF-[beta] family growth factorsGu, Ye January 2012 (has links)
No description available.
|
6 |
Smad2 regulation by heterogeneous nuclear ribonucleoprotein A1 /Hung, Anthony. January 2009 (has links)
Thesis (M.Sc.)--York University, 2009. Graduate Programme in Biology. / Typescript. Includes bibliographical references (leaves 108-139). Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&res_dat=xri:pqdiss&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft_dat=xri:pqdiss:MR51542
|
7 |
The effects of transforming growth factor-β2 on synaptic transmission at the mammalian neuromuscular junctionsFong, Sitt Wai January 2009 (has links)
Transforming growth factor-βs (TGF-βs) are highly expressed in neural development but why the adult nervous system continues to express them is unclear. TGF-β2 is concentrated at mature neuromuscular junctions (NMJs) of mammalian skeletal muscle fibres, and the nerve terminal expresses TβR-II receptors. To test the role of TGF-β2 at mammalian NMJs, I performed four experiments. The first study tested whether TGF-β2 acutely modulates synaptic transmission at mature mammalian NMJs. Second, I asked if chronically reduced TGF-β2 expression disrupts synaptic transmission. Third, I asked if TGF-β2’s effects differ in terminals adapted to different activity patterns in vivo. Lastly, I asked whether TGF-β1, a related peptide to TGF-β2, is distinct in terms of its effects on transmitter release. Using single electrode potential recording, I found TGF-β2 significantly increased the amplitude of spontaneous released single neurotransmitter vesicles (miniature endplate potentials, MEPPs) and nerve stimulation evoked multi-vesicular release (endplate potentials, EPPs). These effects were blocked by L-vesamicol, a vesicular acetylcholine transporter inhibitor, and bafilomycin, a proton pump inhibitor, suggesting the increase in MEPP/EPP amplitude is due to increased vesicle filling presynaptically. These effects were also blocked by the MARK inhibitors, UO126 and PD98059, suggesting TGF-β2 acts via a MARK-dependent pathway. Postsynaptically, two electrode recording showed postsynaptic potential amplitude was enhanced by an increased fibre input resistance, suggesting TGF-β2 also acts postsynaptically. TGF-β2 reduced the number of vesicles released per stimulus (quanta content, QC) but this was blocked by atropine, showing this was indirect through autoreceptor negative feedback. Voltage clamp recording showed TGF-β2 significantly increased the miniature end plate currents (MEPCs), but not the end-plate currents (EPCs), supporting my initial hypothesis that TGF-β2 acts mainly presynaptically to increase vesicle filling. In TGF-β2+/- mice, I found greater MEPP amplitude variability. This supports my previous findings that TGF-β2 modulates vesicle filling. Unexpectedly, there was an excess in larger MEPP sizes (>0.88 mV), perhaps reflecting upregulation of either presynaptic signalling or another synaptic mediator. Two MEPP amplitude populations were induced in TGF-β2-treated TGF-β2+/- mouse NMJs, similar to the bimodal vesicle population in electroplaques. The extensor digitorum longus (EDL, ~95% fast fibres) and soleus (SOL, ~95% slow fibres) were used to investigate whether the TGF-β2-mediated effect differed between fibre types. Overall, TGF-β2 increased the quantal size (MEPP amplitude) in NMJs of both muscles, suggesting this effect is not fibre-type specific and, together with results in mice, that the TGF-β2-mediated increase in vesicle filling is common to all mammalian neuromuscular terminals. With respect to EPP amplitude and QC, the results differed between muscles. In EDL, the EPP amplitude was not significantly changed, whereas it increased in SOL. In EDL, QC was reduced but not in SOL. These difference compared to diaphragm perhaps do reflect muscle fibre-type dependent differences. TGF-β1, at 0.1 ng/ml, significantly reduced quantal size – the opposite of TGF-β2 at any concentration. One explanation would be that a receptor inhibition by TGF-β1 at low concentration interferes with endogenous TGF-β2 binding/receptor activation at the NMJ. However, when the TGF-β1 concentration was raised to 1 ng/ml, like TGF-β2, it significantly increased MEPP amplitude. This suggests that perhaps sufficient binding of TGF-β1 results in the receptor activation of TGF-β2 like signalling. Overall, I conclude that TGF-β2 enhances the size of spontaneous synaptic potentials in all types of muscle fibres, and this is much more rapid (1 hr vs 1 day) than at central neurone synapses in culture. Detailed study in the rat diaphragm shows it increased the evoked EPP amplitude, reduced QC and increased postsynaptic input resistance. Together, TGF-β2 would therefore enhance the postsynaptic depolarisation increasing synaptic strength, and by reducing QC, increase the efficiency of neurotransmission at mammalian NMJs. While unimportant for single stimuli in healthy terminals, by conserving vesicle use, it may help maintain release during stimulus trains, especially during neuromuscular disease.
|
8 |
The TGF-β signalling pathway in Trichinella spiralis : phylogenetic and functional analysis of TGF-β ligandsSheils, Emma January 2011 (has links)
The release of genome sequence information is revolutionising the study of helminth parasites by providing important datasets for comparative genomics, allowing the comprehensive analysis of signalling pathways that regulate nematode development. Much of the current knowledge of nematode signalling pathways is based on studies of the free-living model Caenorhabditis elegans. The recent availability of the Trichinella spiralis genome sequence presented an opportunity to study signalling pathways of this, and other, parasitic nematodes, providing a phylum-wide overview of a given signalling pathway. The transforming growth factor-β (TGF-β) ligands are a superfamily of structurally related polypeptides that regulate a wide range of cellular processes in animal tissues. Since the discovery that the TGF-β daf-7 regulates the developmentally-arrested dauer stage in C. elegans, there is the potential for TGF-β signalling to regulate developmental arrest, parasite development and even host-parasite communication in T. spiralis and other nematodes. In the present study, thirteen genes encoding putative TGF-β signalling components, from T. spiralis, have been identified and characterised. Phylogenetic analysis suggests that daf-7 is not conserved beyond C. elegans and that functional extrapolation from C. elegans biology to distantly-related nematodes is difficult. Furthermore, the analysis herein shows a high level of divergence among parasitic nematode TGF-βs. Since the last common ancestor of T. spiralis and C. elegans was the ancestor of the entire nematode phylum, these comparisons allow speculation on the TGF-β signalling networks of the ancestral nematode and provide information on the emergence of TGF-β signalling in animals. ES products from T. spiralis are shown to be capable of interacting directly with mammalian cell receptors and utilise their receptors to control gene expression in vitro. This presents the possibility that these TGF-β ligands may play a part in the formation and maintenance of the host-parasite complex.
|
9 |
Generation and utilization of knockout mice to elucidate the functions of the TGF-[beta] pathway in mammalian endodermal specification and placental developmentLiu, Ye, January 2006 (has links)
Thesis (Ph. D.)--Ohio State University, 2006. / Full text release at OhioLINK's ETD Center delayed at author's request
|
10 |
TGF-[beta] in mammary development and tumorigenesisBierie, Brian. January 1900 (has links)
Thesis (Ph. D. in Cancer Biology)--Vanderbilt University, Dec. 2008. / Title from title screen. Includes bibliographical references.
|
Page generated in 0.0994 seconds